Table 4 Univariate and multivariate analysis of associations between Ki-67 score and standard variables and cancer-specific survival in 179 women with endometrial cancer

From: Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies

Variable

Univariate analysis

Multivariate analysis

 

HR

95% CI

P-value

HR

95% CI

P-value

Age (1 year)

1.10

1.05–1.15

<0.0001****

1.06

1.001–1.13

0.028*

Body mass index

 <30 kg/m2

1.00

0.52

 ≥30 kg/m2

1.51

0.43–5.25

    

Grade

      

 1

1.00

0.014**

 2

0.584

0.05–6.44

    

 3

4.975

1.17–21.12

    

Stage

      

 1

1.00

<0.0001****

1.00

0.004**

 2

0.96

0.12–7.99

 

3.27

0.34–31.78

 

 3

7.8

3.03–20.11

 

6.44

2.07–20.06

 

 4

23.36

6.49–84.05

 

16.09

2.83–91.36

 

Histological type

 Endometrioid

1.00

<0.0001****

1.00

0.002**

 Non-endometrioid

8.16

3.27–20.39

 

5.72

1.93–16.95

 

Lymphovascular space invasion

 Absent

1.00

    

 Present

4.54

2.21–9.33

<0.0001****

Depth of myometrial invasion

 <50%

1.00

 

 ≥50%

2.46

1.03–5.90

0.043*

   

Any adjuvant therapy

 No

1.00

0.202

 Yes

2.05

0.68–6.19

    

Ki-67 score (10% increase)

1.31

1.07–1.60

0.010**

1.14

0.91–1.41

0.257

  1. Abbreviations: CI, confidence interval; HR, hazard ratio.
  2. Ki-67 was no longer statistically significantly associated with cancer-specific survival when included in the multivariate analysis.
  3. Variables found to be statistically significantly associated with cancer-specific survival in the univariate analysis (P≤0.05) were included in the multivariate analysis; ‘—’ represents not statistically significant in the multivariate analysis. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.